Brief: TCBP Announces Execution Of Non-Binding Letter Of Intent For Acquisition Of NK Platform Technologies
04/04/2024 14:25
April 4 (Reuters) - TC BioPharm Ltd T0Uy.F :
* TCBP ANNOUNCES EXECUTION OF NON-BINDING LETTER OF INTENT
FOR
ACQUISITION OF NK PLATFORM TECHNOLOGIES
Source text for Eikon: ID:nPn42SfwTa
Further company coverage: T0Uy.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TC Biopharm (Holdings)
See all newsBrief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: TC BioPharm Announces Complete Response In Minimal Residual Disease Patient
Brief: TCBP Announces Non-Binding Letter Of Intent To Acquire Commercial Stage Ophthalmic Pharmaceutical Company
Brief: TC Biopharm's Data Show A Favorable Response In Patients With Relapse Or Refractory AML
Brief: TCBP Trading Continues Unabated On Nasdaq Stock Exchange